PDE8A Activators
SEE ALSO...
Items 1 to 10 of 18 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
XAV939 | 284028-89-3 | sc-296704 sc-296704A sc-296704B | 1 mg 5 mg 50 mg | $36.00 $117.00 $525.00 | 26 | |
Inhibits Wnt/β-catenin signaling, potentially affecting SHISA8-related processes. | ||||||
Dipyridamole | 58-32-2 | sc-200717 sc-200717A | 1 g 5 g | $31.00 $102.00 | 1 | |
Dipyridamole, a phosphodiesterase inhibitor, can indirectly enhance PDE8A activity by inhibiting competing PDEs, potentially increasing cAMP specificity and activity of PDE8A in cells. | ||||||
Cilostamide (OPC 3689) | 68550-75-4 | sc-201180 sc-201180A | 5 mg 25 mg | $92.00 $357.00 | 16 | |
Cilostamide, a PDE3 inhibitor, may indirectly increase PDE8A activity by reducing cAMP breakdown through PDE3, potentially leading to more targeted cAMP regulation by PDE8A. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Rolipram, a PDE4 inhibitor, can indirectly enhance PDE8A activity by inhibiting PDE4-mediated cAMP breakdown, potentially amplifying the specific regulatory role of PDE8A in cAMP metabolism. | ||||||
PD173074 | 219580-11-7 | sc-202610 sc-202610A sc-202610B | 1 mg 5 mg 50 mg | $47.00 $143.00 $680.00 | 16 | |
A specific inhibitor of FGF receptors, used in cancer and developmental studies. | ||||||
Milrinone | 78415-72-2 | sc-201193 sc-201193A | 10 mg 50 mg | $165.00 $697.00 | 7 | |
Milrinone, another PDE3 inhibitor, may indirectly enhance PDE8A activity by increasing cAMP levels due to reduced PDE3 activity, leading to a more pronounced role for PDE8A in cAMP regulation. | ||||||
Tadalafil | 171596-29-5 | sc-208412 | 50 mg | $180.00 | 13 | |
Tadalafil, primarily a PDE5 inhibitor, can indirectly enhance PDE8A activity by modulating cGMP levels, potentially affecting cAMP dynamics and PDE8A's regulatory role. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
An HDAC inhibitor, which could affect gene expression, potentially influencing SHISA8. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
An HDAC inhibitor, used in cancer therapy, might affect SHISA8-related pathways. | ||||||
Theophylline | 58-55-9 | sc-202835 sc-202835A sc-202835B | 5 g 25 g 100 g | $20.00 $32.00 $85.00 | 6 | |
Theophylline, a non-specific PDE inhibitor, can indirectly enhance PDE8A activity by broad inhibition of other PDEs, potentially leading to increased PDE8A-mediated cAMP regulation. | ||||||